{
 "generic_name": "Morphine Sulfate Injection",
 "slug": "morphine-sulfate-injection",
 "brand_names": [
  "Duramorph",
  "Infumorph 200",
  "Infumorph 500",
  "Mitigo",
  "Morphine Sulfate"
 ],
 "fda_status": [
  "Current"
 ],
 "last_fda_update": "09/22/2026",
 "first_posted": "10/31/2017",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6020-10",
   "presentation": "Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
  },
  {
   "company": "Amphastar Pharmaceuticals, Inc.",
   "package_ndc": "76329-1912-1",
   "presentation": "Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6019-10",
   "presentation": "Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-452-01",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "76045-004-11",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1890-23",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1890-01",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "76045-005-11",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-454-01",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release October 2026. Check wholesalers for inventory."
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6125-25",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1891-01",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-455-01",
   "presentation": "Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6126-25",
   "presentation": "Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25)",
   "availability": "Unavailable",
   "availability_raw": "unavailable",
   "fda_note": "Additional lots will be available in the October 2026 timeframe.  Product will be made available as it is released."
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6039-01",
   "presentation": "Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Additional lots will be available in the October 2026 timeframe.  Product will be made available as it is released."
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6127-25",
   "presentation": "Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-451-01",
   "presentation": "Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1893-01",
   "presentation": "Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6040-01",
   "presentation": "Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1896-20",
   "presentation": "Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-2022-01",
   "presentation": "Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Piramal Critical Care Inc.",
   "package_ndc": "66794-160-02",
   "presentation": "Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Piramal Critical Care Inc.",
   "package_ndc": "66794-162-02",
   "presentation": "Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3815-12",
   "presentation": "Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3814-12",
   "presentation": "Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  }
 ],
 "changes": []
}